Site Search

... evidenced-based, statewide tobacco prevention and cessation programs. A 2008 study, published jointly by the Society and other leading health organizations, concluded that regions of the country with weak tobacco control policies that do not include effective strategies in all ... in the price of cigarettes reduces youth smoking by 7 percent and overall cigarette consumption by about 4 percent. Secondhand smoke is a major health hazard, proven to cause lung cancer, heart disease and emphysema. With 4,000 chemicals and more than 60 carcinogens – including arsenic ... remains the nation’s number one cause of preventable death, killing more than 400,000 Americans and costing $96 billion in direct health care costs each year. The report is available on the CDC website: www.cdc.gov/tobacco . ACS CAN, the nonprofit, nonpartisan advocacy affiliate of ...

... allow flavored e-cigarettes to be available to New York’s kids are essential to achieving these goals, and will have positive impacts on the health of New Yorkers for generations to come. With approximately 12% of New York adults still smoking and 28,200 New Yorkers projected to die from ... Tax Increases Increasing the cigarette tax by $1 per pack, moving it from $4.35 to $5.35 per pack is projected to generate significant public health benefits for New Yorkers. Among other health benefits, the new tax proposal would also have significant public health benefits including: ... Campaign for Tobacco-Free Kids Center for Black Health & Equity Columbia University Herbert Irving Comprehensive Cancer Center Community Health Care Association of New York State Interfaith Public Health Network. Memorial Sloan Kettering Cancer Center Montefiore Health System Mount Sinai ...

... them, giving doctors the right amount of information to make a therapy decision. The National Cancer Institute at the National Institutes of Health has recognized the potential impact of targeted NGS on cancer and is using it to help match patients to ongoing drug trials through its ... Doctors and healthcare networks have a responsibility to their patients to provide the most effective innovations so patients get the right care.  The issue of economics, on the other hand, is harder to overcome. NGS-based tests provide a significantly higher value to patients and ... Medicare and Medicaid – can help tremendously by coordinating NGS-focused trials across multiple labs to exponentially expand patient and health economics data. The information they gather would help establish clinical utility and cost justification, which is what insurers rightfully ...

... that they are generally larger, more complex molecules. Biologics are usually administered via injection or infusion. Most biologics in cancer care are given under the close supervision of a medical professional.  Biologics have been a part of medical treatment for a long time and have ... one, some, or all of the conditions of the reference product. While the safety of a biosimilar is assured through FDA review and approval, your health care provider should review the product label for any prescribed biosimilar.  Why biosimilars were introduced Biosimilars were introduced ... to you by your healthcare provider. This might be for several reasons, including that the biosimilar is the preferred product of your doctor or health plan. This preference might also come from physician’s experience with the product, a desire by your health plan to control costs, or ...